Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review - Wikidata - wikimedia - TriplyDB

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

http://www.wikidata.org/entity/Q26801835

about

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.Cardiovascular safety of antipsychotics: a clinical overview.First-generation antipsychotics and QTc: any role for mediating variables?Post-mortem toxicology in young sudden cardiac death victims: A nationwide cohort study.Cardiac Sudden Death in Psychiatric Patients.Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study The Role of Cannabis within an Emerging Perspective on Schizophrenia

P2860

Q28553078-BF887312-86FA-46B9-8FE8-811014FE5308 Q38704005-1349C3E9-2A52-44FA-9568-CFD86EA1FEC3 Q38757870-742BF7E3-29A1-4B77-B732-FC88B3AB1191 Q39721569-260C0FCF-51E6-475F-82E3-39506C093459 Q40275320-82D4579B-2A0B-4E87-9000-465F1998EF26 Q42390649-6566ACAF-B1F6-4F81-9764-5B10FC5FBCBA Q55232340-4DE2D703-C85C-4C58-B329-6A029CA0D786 Q58561595-A98D1E7B-C37B-4730-9795-F2130E06C9CD Q58794814-5D8338F3-63C6-44CF-8793-03FAAB832553

P2860

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

http://www.wikidata.org/entity/Q26801835

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@ast

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@en

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@nl

type

label

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@ast

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@en

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@nl

prefLabel

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@ast

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@en

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@nl

P1433

Q26801835-4189794C-EFDC-4301-BA7A-B1F49F7EAD18

P1476

Q26801835-350319C3-9DC9-4082-B17B-301921180306

P2093

Q26801835-3FBCB65F-E998-4BB6-8071-06E44E6CBAF7

Q26801835-7FF0CA13-8462-4956-ACB8-9F68BD14373C

Q26801835-E7F76767-01B2-43DB-8835-8F9B72C3A120

P2860

Q26801835-0785EBA1-A23E-48E1-9A08-A359819520EA

Q26801835-0BF00EF9-F1EB-4D61-8D96-629812B3AB91

Q26801835-0DC00E23-6EDC-47A7-BE47-3A70FFD7FA75

Q26801835-1438B63B-5569-41D5-96CD-B3674F83771A

Q26801835-2C4149B4-A4B3-4E3F-89FE-734E8B66F14F

Q26801835-2F724744-CF20-475B-ABD9-C0CB86CE6A4A

Q26801835-39CE2EA8-1AFA-49D6-953E-18057CFBF999

Q26801835-3DBD4023-4BF4-4183-A22C-72825BC5A848

Q26801835-409155B6-6C38-4BB5-B7B6-B80746CD5110

Q26801835-4CCE510F-E96D-46C2-A317-55AEFD4AB7F3

P304

Q26801835-E9FDA79A-94F3-4702-BE8C-5257EFE463F5

P31

Q26801835-7190ADD5-3420-4B3A-B291-CACD499148AD

Q26801835-988CFD23-CAF2-43BB-BD83-C8C9AB620332

P356

Q26801835-247E219C-5BFE-4906-A76C-590984DC40EF

P407

Q26801835-5C47FB84-81BF-4AAF-A7D2-5D201F80B5CD

P433

Q26801835-C537FD03-E99E-4163-819E-320DED97338C

P478

Q26801835-BE363AEF-81E0-43E7-8E41-BB23615DB710

P50

Q26801835-6192C4A8-A06E-40BE-B662-05920BC7DDD1

P577

Q26801835-33C2BAD7-41EC-41DC-A4F5-910DBC0FAEAD

P698

Q26801835-DC87BDF5-E180-40F9-B0E5-39FDC3AA9421

P932

Q26801835-74350E68-4DE9-4116-88B6-69549E08223E

P356

070674371506000503

P1433

Canadian Journal of Psychiatry

P1476

Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review

@en

P2093

Hiroyoshi Takeuchi

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Uchida

http://www.w3.org/2001/XMLSchema#string

Takefumi Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

Combined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation.

Risk stratification in the long-QT syndrome.

QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.

Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.

Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.

Electrocardiographic QT interval and mortality: a meta-analysis.

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

P304

215-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1177/070674371506000503

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26174525

http://www.w3.org/2001/XMLSchema#string

P932

4484690

http://www.w3.org/2001/XMLSchema#string